Login / Signup
Bin Shen
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Squamous Cell
Growth Factor
Clinical Trial
Small Cell Lung Cancer
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Bin Shen
,
Jueping Shi
,
Zhixuan Zhu
,
Zhidong He
,
Shenyan Liu
,
Wan Shi
,
Yongxian Zhang
,
Haiyan Ying
,
Jie Wang
,
Ruifeng Xu
,
Fei Fang
,
Harrison Xuesong Chang
,
Zhui Chen
,
Nannan Zhang
EGFR inhibition overcomes resistance to FGFR4 inhibition and potentiates FGFR4 inhibitor therapy in hepatocellular carcinoma.
Molecular cancer therapeutics
(2023)